Effects of losartan on catecholamine release in the isolated rat adrenal gland

Korean Journal of Physiology and Pharmacology

Volumn 13, Issue 4, 2009, Pages 327-335

  Noh, Hae Jeong ^a   Kang, Yoon Sung ^b   Lim, Dong Yoon ^b  

^a Eulji University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Adrenal medulla; AT1 receptor blockade; Catecholamine release; Losartan

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; 1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; ACETYLCHOLINE; ANGIOTENSIN II; CYCLOPIAZONIC ACID; LOSARTAN; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; POTASSIUM ION; VERATRIDINE;

ADRENAL MEDULLA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CHOLINERGIC STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; ISOLATED ORGAN; MALE; MEMBRANE DEPOLARIZATION; NONHUMAN; ORGAN PERFUSION; RAT; RECEPTOR BLOCKING;

EID: 70349397635     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2009.13.4.327     Document Type: Article

References (51)

1. Aguilera G, Kiss A, Luo X. Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration. J Neuroendocrinol 7: 775-783, 1995.
2. Anton AH, Sayre DF. A study of the factors affecting the aluminum oxidetrihydroxy indole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138: 360-375, 1962.
3. 1 receptor antagonist decreases the hypothalamic-pituitary-adrenal response to isolation stress. Endocrinology 142: 3880-3889, 2001.
4. Armando I, Jezova M, Bregonzio C, Baiardi G, Saavedra JM. Angiotensin II AT1 and AT2 receptor types regulate basal and stress-induced adrenomedullary catecholamine production through transcriptional regulation of tyrosine hydroxylase. Ann NY Acad Sci 1018: 302-309, 2004.
5. Barber MN, Sampey DB, Widdop RE. AT(2) receptor stimulation enhances antihypertensive effect of AT(1) receptor antagonist in hypertensive rats. Hypertension 34: 1112-1116, 1999.
6. Bunn SJ, Marley PD. Effects of angiotensin II on cultured, bovine adrenal medullary cells. Neuropeptides 13: 121-132, 1989.
7. Castrén E, Saavedra JM. Repeated stress increases the density of angiotensin II binding sites in the rat paraventricular nucleus and subfornical organ. Endocrinology 122: 370-372, 1988.
8. Catterall WA. Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev 72: 15-48, 1992.
9. Catterall WA. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26: 13-25, 2000.
10. Challiss RA, Jones JA, Owen PJ, Boarder MR. Changes in inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate mass accumulations in cultured adrenal chromaffin cells in response to bradykinin and histamine. J Neurochem 56: 1083-1086, 1991.
11. 2+ in bovine adrenal chromaffin cells: Distinct nicotinic and muscarinic patterns. FEBS Lett 247: 429-434, 1989.
12. Critchley L, Ding B, Fok B, Wang D, Tomlinson B, James A, Thomas GN, Critchley J. The effects of candesartan and ramipril on adrenal catecholamine release in anaesthetized dogs. Eur J Pharmacol 489: 67-75, 2004.
13. Dendorfer A, Raasch W, Tempel K, Dominiak P. Interactions between the renin-angiotensin system (RAS) and the sympathetic system. Basic Res Cardiol 93: 24-29, 1998.
14. Dunn LA, Holz RW. Catecholamine secretion from digitonin-treated adrenal medullary chromaffin cells. J Biol Chem 258: 4989-4993, 1983.
15. Garcia AG, Sala F, Reig JA, Viniegra S, Frias J, Fonteriz R, Gandia L. Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature 309: 69-71, 1984.
16. Ghosh A, Greenberg ME. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268: 239-247, 1995.
17. 2+ permeability. Biochem Pharmacol 38: 3995-4003, 1989.
18. 2 biochemical and functional characterization. Life Sci 31: 2992-2998, 1982.
19. + transport by angiotensin II in primary renal cells. Kidney Int 57: 2457-2467, 2000.
20. Hano T, Mizukoshi M, Baba A, Nakamura N, Nishio I. Angiotensin II subtype 1 receptor modulates epinephrine release from isolated rat adrenal gland. Blood Press 5: 105-108, 1994.
21. 2+ uptake and catecholamine secretion in primary dissociated cultures of adrenal modulla. J Neurochem 39: 635-640, 1982.
22. Israel A, Strömberg C, Tsutsumi K, Garrido MR, Torres M, Saavedra JM. Angiotensin II receptor subtypes and phosphoinositide hydrolysis in rat adrenal medulla. Brain Res Bull 38:441-446, 1995.
23. Kubo T, Numakura H, Endo S, Hagiwara Y, Fukumori R. Angiotensin receptor blockade in the anterior hypothalamic area inhibits stress-induced pressor responses in rats. Brain Res Bull 56: 569-574, 2001.
24. Lim DY, Kim CD, Ahn KW. Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch Pharm Res 15: 115-125, 1992.
25. Livett BG, Marley PD. Non cholinergic control of adrenal catecholamine secretion. J Anat 183: 277-289, 1993.
26. Martineau D, Lamouche S, Briand R, Yamaguchi N. Functional involvement of angiotensin AT2 receptor in adrenal catecholamine secretion in vivo. Can J Physiol Pharmacol 77: 367-374, 1999.
27. Martineau D, Yamaguchi N, Briand R. Inhibition by BMS 186295, a selective nonpeptide AT1 antagonist, of adrenal catecholamine release induced by angiotensin II in the dog in vivo. Can J Physiol Pharmacol 73: 459-464, 1995.
28. McGehee DS, Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57: 521-546, 1995.
29. Nahmod VE, Finkielman S, Benarroch EE, Pirola CJ. Angiotensin regulates release and synthesis of serotonin in brain. Science 202: 1091-1093, 1978.
30. Phillips MI, Speakman EA, Kimura B. Levels of angiotensin and molecular biology of the tissue rennin angiotensin systems. Regul Pept 43: 1-20, 1993.
31. Plunkett LM, Correa FM, Saavedra JM. Quantitative autoradiographic determination of angiotensin-converting enzyme binding in rat pituitary and adrenal glands with 124I-351A, a specific inhibitor. Regul Pept 28: 263-272, 1985.
32. + depolarization or by carbachol. J Neurochem 57: 1461-1469, 1991.
33. Saavedra JM. Brain and pituitary angiotensin. Endocr Rev 13: 329-380, 1992.
34. Saiki Y, Watanabe T, Tan N, Matsuzaki M, Nakamura S. Role of central ANG-II receptors in stress-induced cardiovascular and hyperthermic responses in rats. Am J Physiol 272: 26-33, 1997.
35. 2+-ATPase of sarcoplasmic reticulum. J Biol Chem 264: 17816-17823, 1989.
36. Seltzer A Bregonzio C, Armando I, Baiardi G, Saavedra JM. Oral administration of an ATI receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats. Brain Res 1028: 9-18, 2004.
37. Stoehr SJ, Smolen JE, Holz RW, Agranoff BW. Inositol trisphosphate mobilizes intracellular calcium in permeabilized adrenal chromaffin cells. J Neurochem 46: 637-640, 1986.
38. + currents in guinea-pig smooth muscle cells. Br J Pharmacol 107: 134-140, 1992.
39. Swope SL, Moss SJ, Blackstone CD, Huganir RL. Phosphorylation of ligand-gated ion channels: a possible mode of synaptic plasticity. FASEB J 6: 2514-2523, 1992.
40. 2+-dependent manner through a decrease of cyclic guanosine 3′,5′-monophosphate production in cultured porcine adrenal medullary chromaffin cells. Endocrinol 142: 3075-3086, 2001.
41. Tallarida RJ, Murray RB. Manual of pharmacologic calculation with computer programs. 2nd ed. Speringer-Verlag, New York, p 132, 1987.
42. Teschemacher AG, Seward EP. Bidirectional modulation of exocytosis by angiotensin II involves multiple G-protein-regulated transduction pathways in chromaffin cells. The J Neurosci 20: 4776-4785, 2000.
43. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Smith RD. New perspectives in angiotensin system control. J Hum Hypertens 7: 19-31, 1993.
44. Uresin Y, Erbas B, Ozek M, Ozkök E, Gürol AO. Losartan may prevent the elevation of plasma glucose, corticosterone and catecholamine levels induced by chronic stress. J Renin Angiotensin Aldosterone Syst 5: 93-96, 2004.
45. Vijayapandi P, Nagappa AN. Biphasic effects of losartan potassium on immobility in mice. Yakugaku Zasshi 125: 653-657, 2005.
46. 45Ca influx and secretion of catecholamines in cultured bovine adrenal medulla cells. Neuroscience 15: 283-292, 1985.
47. Wakade AR. Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland. J Physiol 313: 463-480, 1981.
48. Wong PC, Hart SD, Zaspel AM, Chiu AT, Ardecky RJ, Smith RD, Timmermans PB. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). J Pharmacol Exp Ther 255: 584-592, 1990.
49. 2 receptor blockade and epinephrine release during insulin-induced hypoglycemia. Hyperten 31: 384-390, 1998.
50. Yang G, Xi Z, Wan Y, Wang H, Bi G. Changes in circulating and tissue angiotensin II during acute and chronic stress. Biol Signals 2: 166-172, 1993.
51. Zaman MA, Oparil S, Calhoun DA. Drugs targeting the renin-angiotensin- aldosterone system. Nat Rev Drug Discov 1: 621-636, 2002.